Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Trelle

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Trials|August 23, 2020
Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)-rationale and design for an international collaborative studyBenjamin Kasenda, Junhao Liu, Yu Jiang, et al.
JAMA Network Open|January 28, 2025
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical TrialAlexandros A Polymeris, Mattia Branca, P N Sylaja, et al.
European Stroke Journal|December 8, 2022
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trialUrs Fischer, Sven Trelle, Mattia Branca, et al.
BMC Nephrology|December 12, 2018
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trialNasser A Dhayat, Nicolas Faller, Olivier Bonny, et al.
The New England Journal of Medicine|March 1, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceNasser A Dhayat, Olivier Bonny, Beat Roth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2025
Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones: Post Hoc Analysis of the NOSTONE TrialAndreas Christe, Elias Primetis, Grazia M Cereghetti, et al.
Circulation|May 16, 2024
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN TrialRoman Rohner, Markus Kneihsl, Martina B Goeldlin, et al.
BMJ Open|June 6, 2019
Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trialLuise Adam, Elisavet Moutzouri, Christine Baumgartner, et al.
Lancet (London, England)|September 18, 2007
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisChristoph Stettler, Simon Wandel, Sabin Allemann, et al.
Lancet (London, England)|August 8, 2015
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trialAna Maria Henao-Restrepo, Ira M Longini, Matthias Egger, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Trials|August 23, 2020
Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)-rationale and design for an international collaborative studyBenjamin Kasenda, Junhao Liu, Yu Jiang, et al.
JAMA Network Open|January 28, 2025
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical TrialAlexandros A Polymeris, Mattia Branca, P N Sylaja, et al.
European Stroke Journal|December 8, 2022
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trialUrs Fischer, Sven Trelle, Mattia Branca, et al.
BMC Nephrology|December 12, 2018
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trialNasser A Dhayat, Nicolas Faller, Olivier Bonny, et al.
The New England Journal of Medicine|March 1, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceNasser A Dhayat, Olivier Bonny, Beat Roth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2025
Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones: Post Hoc Analysis of the NOSTONE TrialAndreas Christe, Elias Primetis, Grazia M Cereghetti, et al.
Circulation|May 16, 2024
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN TrialRoman Rohner, Markus Kneihsl, Martina B Goeldlin, et al.
BMJ Open|June 6, 2019
Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trialLuise Adam, Elisavet Moutzouri, Christine Baumgartner, et al.
Lancet (London, England)|September 18, 2007
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisChristoph Stettler, Simon Wandel, Sabin Allemann, et al.
Lancet (London, England)|August 8, 2015
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trialAna Maria Henao-Restrepo, Ira M Longini, Matthias Egger, et al.
Pageof 10